Patents by Inventor Henrick S. Olsen

Henrick S. Olsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human stanniocalcin-alpha
    Patent number: 6613877
    Abstract: A human stanniocalcin-alpha polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for the regulation of electrolyte imbalances which can lead to renal, bone and heart diseases and osteoporosis and Paget's Disease. Antagonists against such polypeptides and their use in the regulation of electrolyte imbalances which can lead to hypocalcemia and osteoporosis are also disclosed.
    Type: Grant
    Filed: July 28, 1999
    Date of Patent: September 2, 2003
    Assignee: Human Genome Sciences, Inc.
    Inventors: Henrick S. Olsen, Robert D. Fleischmann
  • Human haemopoietic maturation factor polypeptides
    Patent number: 5986069
    Abstract: Disclosed is human haemopoietic maturation factor polypeptides and DNA (RNA) encoding such haemopoietic maturation factor polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques and the use of such polypeptides for treating leukemia, auto-immune diseases and blood related disorders. Antagonists against such polypeptides and their use as a therapeutic to prevent expansion of T-cell populations is also disclosed. Diagnostic assays are also disclosed which detect the presence of mutations in the haemopoietic maturation factor nucleic acid sequences and altered levels of the protein.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: November 16, 1999
    Assignee: Human Genome Sciences, Inc.
    Inventors: Ewen F. Kirkness, Mark D. Adams, Henrick S. Olsen, Craig A. Rosen